Erin Lew

Erin Lew is a seasoned scientist with extensive experience in oncology and immunotherapy research. Currently serving as a Senior Principal Scientist at Erasca, Inc. since October 2018, Erin has previously held positions as Principal Scientist and Senior Scientist. Prior experience includes a role as Senior Scientist I at IGNYTA, Inc., where leadership of a preclinical research team contributed to the successful IND application of an immuno-oncology asset. At IGNYTA, Erin played a pivotal role in various research development phases and managed collaborations with internal and external entities. At The Salk Institute for Biological Studies, Erin focused on protein biologics and receptor tyrosine kinases. Erin's academic foundation includes a PhD in Pharmacology from Yale University, where the research revolved around the regulation of FGF receptor autophosphorylation. Erin holds a Bachelor of Science in Biomedical Engineering from Northwestern University.